Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis
Latest Information Update: 04 Oct 2023
At a glance
- Drugs Apixaban (Primary)
- Indications Deep vein thrombosis; Venous thromboembolism
- Focus Therapeutic Use
- Acronyms ARM-DVT
- Sponsors Intermountain Healthcare
- 26 Sep 2023 Status changed from suspended to discontinued.
- 24 Aug 2021 Status changed from recruiting to suspended due to COVID-19 resource allocation.
- 11 Feb 2020 Planned End Date changed from 1 Oct 2019 to 31 Dec 2023.